The Enterprise Value as of June 2026 (TTM) for Curanex Pharmaceuticals Inc Common Stock (CURX) is 5.39M

According to Curanex Pharmaceuticals Inc Common Stock’s latest financial reports and current stock price. The company's current Enterprise Value is 5.39M. This represents a change of -84.51% compared to the average of 34.79M of the last 4 quarters.

Curanex Pharmaceuticals Inc Common Stock (CURX) Historical Enterprise Value (quarterly & annually)

How has CURX Enterprise Value performed in the past?

The mean historical Enterprise Value of Curanex Pharmaceuticals Inc Common Stock over the last ten years is 70.99M. The current 5.39M Enterprise Value has changed 659.20% with respect to the historical average. Over the past ten years (40 quarters), CURX's Enterprise Value was at its highest in in the June 2025 quarter at 111.92M. The Enterprise Value was at its lowest in in the September 2024 quarter at -244320.00.

Curanex Pharmaceuticals Inc Common Stock (CURX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Curanex Pharmaceuticals Inc Common Stock Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Curanex Pharmaceuticals Inc Common Stock (CURX) Average Enterprise Value

How has CURX Enterprise Value performed in the past?

The current Enterprise Value of Curanex Pharmaceuticals Inc Common Stock (CURX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Curanex Pharmaceuticals Inc Common Stock (CURX) Enterprise Value vs. Peers

How is CURX’s Enterprise Value compared to its peers?

Curanex Pharmaceuticals Inc Common Stock’s Enterprise Value is greater than Pulmatrix, Inc. (1.79M), greater than Aspire Biopharma Holdings, Inc. (-4785565.00), less than Palisade Bio, Inc. (164.19M), greater than Longeveron Inc. (590.68K), less than Hoth Therapeutics, Inc. (20.84M), greater than Curis, Inc. (-8118049.00), less than Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (11.03M), less than Leap Therapeutics, Inc. (30.18M), less than Daré Bioscience, Inc. (7.90M), greater than BriaCell Therapeutics Corp. (-1762096.56),

Build a custom stock screener for Curanex Pharmaceuticals Inc Common Stock (CURX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Curanex Pharmaceuticals Inc Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Curanex Pharmaceuticals Inc Common Stock (CURX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Curanex Pharmaceuticals Inc Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.